Asset Management
Compare Stocks
2 / 10Stock Comparison
ASST vs GROW
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management - Global
ASST vs GROW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management - Global |
| Market Cap | $27M | $35M |
| Revenue (TTM) | $3M | $8M |
| Net Income (TTM) | $-217M | $98K |
| Gross Margin | 89.2% | 41.7% |
| Operating Margin | -11.7% | -35.3% |
| Total Debt | $4M | $83K |
| Cash & Equiv. | $67M | $25M |
ASST vs GROW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 23 | May 26 | Return |
|---|---|---|---|
| Strive, Inc. (ASST) | 100 | 9.8 | -90.2% |
| U.S. Global Investo… (GROW) | 100 | 92.3 | -7.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ASST vs GROW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ASST is the clearest fit if your priority is growth exposure.
- Rev growth 476.2%, EPS growth 98.6%, 3Y rev CAGR 119.9%
- 476.2% revenue growth vs GROW's -23.1%
- +33.4% vs GROW's +29.0%
GROW carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.71, yield 3.5%
- 64.9% 10Y total return vs ASST's -95.4%
- Lower volatility, beta 0.71, Low D/E 0.2%, current ratio 20.87x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 476.2% revenue growth vs GROW's -23.1% | |
| Quality / Margins | -4.0% margin vs ASST's -74.6% | |
| Stability / Safety | Beta 0.71 vs ASST's 2.47, lower leverage | |
| Dividends | 3.5% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +33.4% vs GROW's +29.0% | |
| Efficiency (ROA) | 0.2% ROA vs ASST's -108.1%, ROIC -4.7% vs -40.0% |
ASST vs GROW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ASST vs GROW — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GROW leads this category, winning 3 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
GROW is the larger business by revenue, generating $8M annually — 2.9x ASST's $3M. GROW is the more profitable business, keeping -4.0% of every revenue dollar as net income compared to ASST's -74.6%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3M | $8M |
| EBITDAEarnings before interest/tax | -$34M | -$2M |
| Net IncomeAfter-tax profit | -$217M | $98,000 |
| Free Cash FlowCash after capex | -$45M | -$235,000 |
| Gross MarginGross profit ÷ Revenue | +89.2% | +41.7% |
| Operating MarginEBIT ÷ Revenue | -11.7% | -35.3% |
| Net MarginNet income ÷ Revenue | -74.6% | -4.0% |
| FCF MarginFCF ÷ Revenue | -15.6% | -9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +56.8% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +89.9% | — |
Valuation Metrics
GROW leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $27M | $35M |
| Enterprise ValueMkt cap + debt − cash | -$37M | $10M |
| Trailing P/EPrice ÷ TTM EPS | -1.67x | -104.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 7.44x | 4.14x |
| Price / BookPrice ÷ Book value/share | 0.24x | 0.77x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
GROW leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
GROW delivers a 0.2% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-110 for ASST. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to ASST's 0.02x. On the Piotroski fundamental quality scale (0–9), ASST scores 3/9 vs GROW's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -110.0% | +0.2% |
| ROA (TTM)Return on assets | -108.1% | +0.2% |
| ROICReturn on invested capital | -40.0% | -4.7% |
| ROCEReturn on capital employed | -6.1% | -6.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 2 |
| Debt / EquityFinancial leverage | 0.02x | 0.00x |
| Net DebtTotal debt minus cash | -$64M | -$24M |
| Cash & Equiv.Liquid assets | $67M | $25M |
| Total DebtShort + long-term debt | $4M | $83,000 |
| Interest CoverageEBIT ÷ Interest expense | -186463.21x | 600.00x |
Total Returns (Dividends Reinvested)
GROW leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GROW five years ago would be worth $4,258 today (with dividends reinvested), compared to $459 for ASST. Over the past 12 months, ASST leads with a +33.4% total return vs GROW's +29.0%. The 3-year compound annual growth rate (CAGR) favors GROW at 1.1% vs ASST's -44.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -5.9% | +7.7% |
| 1-Year ReturnPast 12 months | +33.4% | +29.0% |
| 3-Year ReturnCumulative with dividends | -83.0% | +3.3% |
| 5-Year ReturnCumulative with dividends | -95.4% | -57.4% |
| 10-Year ReturnCumulative with dividends | -95.4% | +64.9% |
| CAGR (3Y)Annualised 3-year return | -44.6% | +1.1% |
Risk & Volatility
GROW leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GROW is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than ASST's 2.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GROW currently trades 71.8% from its 52-week high vs ASST's 6.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.47x | 0.71x |
| 52-Week HighHighest price in past year | $268.40 | $3.65 |
| 52-Week LowLowest price in past year | $0.84 | $2.10 |
| % of 52W HighCurrent price vs 52-week peak | +6.1% | +71.8% |
| RSI (14)Momentum oscillator 0–100 | 66.7 | 45.3 |
| Avg Volume (50D)Average daily shares traded | 3.6M | 25K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
GROW is the only dividend payer here at 3.46% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | $1.50 | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +3.5% |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | $0.09 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.6% |
GROW leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics.
ASST vs GROW: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ASST or GROW a better buy right now?
For growth investors, Strive, Inc.
(ASST) is the stronger pick with 476. 2% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ASST or GROW?
Over the past 5 years, U.
S. Global Investors, Inc. (GROW) delivered a total return of -57. 4%, compared to -95. 4% for Strive, Inc. (ASST). Over 10 years, the gap is even starker: GROW returned +64. 9% versus ASST's -95. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ASST or GROW?
By beta (market sensitivity over 5 years), U.
S. Global Investors, Inc. (GROW) is the lower-risk stock at 0. 71β versus Strive, Inc. 's 2. 47β — meaning ASST is approximately 250% more volatile than GROW relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 2% for Strive, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ASST or GROW?
By revenue growth (latest reported year), Strive, Inc.
(ASST) is pulling ahead at 476. 2% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Strive, Inc. grew EPS 98. 6% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ASST or GROW?
U.
S. Global Investors, Inc. (GROW) is the more profitable company, earning -4. 0% net margin versus -591. 2% for Strive, Inc. — meaning it keeps -4. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GROW leads at -35. 3% versus -620. 7% for ASST. At the gross margin level — before operating expenses — GROW leads at 41. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ASST or GROW?
In this comparison, GROW (3.
5% yield) pays a dividend. ASST does not pay a meaningful dividend and should not be held primarily for income.
07Is ASST or GROW better for a retirement portfolio?
For long-horizon retirement investors, U.
S. Global Investors, Inc. (GROW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), 3. 5% yield). Strive, Inc. (ASST) carries a higher beta of 2. 47 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GROW: +64. 9%, ASST: -95. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ASST and GROW?
These companies operate in different sectors (ASST (Communication Services) and GROW (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ASST is a small-cap high-growth stock; GROW is a small-cap income-oriented stock. GROW pays a dividend while ASST does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 28%
- Gross Margin > 53%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.